Analysis of Tuberculosis Fatal Risk Factors in the Patients Hospitalized with COVID-19

The objective: to analyze risk factors of the unfavorable course of tuberculosis detected in the patients hospitalized with suspected COVID-19.

Subjects and Methods. Of 1079 patients hospitalized with suspected COVID-19 and pneumonia, 120 case histories of patients with tuberculosis were retrospectively selected using a continuous sampling method; the fatal outcome was reported in 17.5% of cases (21/120).

Results. Chronic kidney disease, diabetes mellitus, and underweight were more common among patients with a fatal outcome. Of the laboratory data, the most significant risk factors for an unfavorable outcome were as follows: levels of hemoglobin below 110 g/l, total protein below 60.4 g/l, D-dimer above 2.21 μg/ml, and C-reactive protein above 91.9 mg/l.

1. Borodulina E.A., Vdushkina E.S., Kuznetsova A.N., Gladunova E.P. Features of concomitant HIV/tuberculosis diseases with fatal outcomes. HIV Infection and Immunosuppressive Disorders, 2019, vol. 11, no. 4, pp. 70-78. (In Russ.)

2. Borodulina E.A. The issue of tuberculosis detection in general medical services. Vrach, 2023, vol. 34, no. 2, pp. 5-10. (In Russ.)

3. Vostroknutov M.E. Analysis of lethal outcomes in patients with HIV/tuberculosis co-infection undergoing inpatient treatment in penitentiaries. Consilium Medicum, 2019, vol. 21, no. 3, pp. 33-36. (In Russ.)

4. Ivanova D.A., Belilovsky E.M., Bogorodskaya E.M., Reshetnikov M.N., Plotkin D.V., Avdentova V.B. The influence of comorbidities on treatment outcomes in patients with tuberculosis. Terapevticheskiy Arkhiv, 2024, vol. 96, no. 8, pp. 790-796. (In Russ.)

5. Klester E.B., Schigareva M.S., Lyashko P.V., Khachatryan L.G., Klester K.V. Clinical and epidemiological characteristics of tuberculosis and COVID-19 co-infection. Journal Infectology, 2021, vol. 13, no. 2, pp. 44. (In Russ.)

6. Kotova E.A., Sumarokova E.V., Belilovsky E.M. The co-infection of COVID-19 among tuberculosis patients in the city of Moscow. Tuberkulez i Sotsialno-Znachimye Zabolevaniya, 2023, vol. 11, no. 1, pp. 12-15. (In Russ.)

7. Mayseyenko V.I., Buynevich I.V., Tumash O.L. Specific features of pulmonary tuberculosis/COVID-19 co-infection. Journal Infectology, 2023, vol. 15, no. 2, pp. 76. (In Russ.)

8. Mikhaylova N.R., Mikhaylovsky A.M., Plastamak O.N., Kalinina T.N., Zhdanova D.A., Emelyanova L.A., Nuriakhmetova O.V. Analysis of causes of lethal outcomes in the patients with TB/HIV co-infection in a TB dispensary. Journal Infectology, 2023, vol. 15, no. 2, pp. 88. (In Russ.)

9. Puzyreva L.V., Mordyk A.V., Rudenko S.A., Antropova V.V., Zhigalova L.A., Pugachev A.N., Nikolaeva I.I., Shestak E.M. The analysis of death outcomes in patients of anti-tuberculosis dispensary: tuberculosis in combination with HIV infection. Medical News of North Caucasus, 2017, vol. 12, no. 2, pp. 169-172. (In Russ.)

10. Savintseva E.V., Isaeva P.V., Nizamova G.F. Tuberculosis and COVID-19: medical and social aspects. Tuberculosis and Lung Diseases, 2022, vol. 100, no. 3, pp. 13-17. (In Russ.)

11. Saenko S.S., Sterlikov S.A., Rusakova L.I., Gaevaya I.S., Nagibina L.A., Frolov E.G., Yukhnova E.A., Novikova T.V., Kononenko Yu.S., Podgaynaya O.A., Svicharskaya A.K., Gudenkov M.A., Surnacheva I.F., Pirogova N.D., Lechleyder M.V. Predictors of a lethal outcome in patients with TB/HIV co-infection. Current Problems of Health Care and Medical Statistics, 2020, no. 1, pp. 314-334. (In Russ.)

12. Shishkina E.R., Ergeshova L.A., Egorova A.D., Evseeva N.I., Gordeeva O.M., Kiseleva E.A. Respiratory tuberculosis and novel corovirus infection of COVID-19 - the current reality. CTRI Bulletin, 2021, no. 1, pp. 240-241. (In Russ.)

13. Duzgun S.A., Durhan G., Demirkazik F.B. et al. COVID-19 pneumonia: the great radiological mimicker. Insights Into Imaging, 2020, no. 11, pp. 118. https://doi.org/10.1186/s13244-020-00933-z

14. Hasan M.J., Akther A., Fardous J., Khan M.A.S. Syndemic of tuberculosis and COVID-19 in Bangladesh. Asia Pacific Journal of Public Health, 2021, vol. 33, no. 8, pp. 992-994. https://doi.org/10.1177/10105395211034073

15. Matatiele M., Stiegler N., Bouchard J.P. Tri-infection: Tuberculosis, HIV, COVID-19 and the already strained South African health system. Brain, Behavior and Immunity, 2021, no. 96, pp. 5-6. https://doi.org/10.1016/j.bbi.2021.06.007

16. Petrone L., Petruccioli E., Vanini V., Cuzzi G., Gualano G.,Vittozzi P. et al. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2. International Journal of Infectious Diseases, 2021, vol. 113, suppl. 1, pp. S63-S67. https://doi.org/10.1016/j.ijid.2021.02.090

17. Shabrawishi M., AlQarni A., Ghazawi M., Melibari B., Baljoon T., Alwafi H. et al. New disease and old threats: a case series of COVID-19 and tuberculosis coinfection in Saudi Arabia. Clinical Case Reports, 2021, no. 9, pp. e04233. https://doi.org/10.1002/ccr3.4233

18. Singh A., Prasad R., Gupta A., Das K., Gupta N. Severe acute respiratory syndrome coronavirus-2 and pulmonary tuberculosis: convergence can be fatal. Monaldi Archives for Chest Disease, 2020, vol. 90, no. 3. https://doi.org/10.4081/monaldi.2020.1368